gastrointestinal Clinical Trials in Houston, Texas
21 recruitingHouston, Texas
Showing 1–20 of 21 trials
Recruiting
Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Pancreatic Neuroendocrine TumorVon Hippel-Lindau DiseasePheochromocytoma/Paraganglioma+2 more
Merck Sharp & Dohme LLC322 enrolled84 locationsNCT04924075
Recruiting
Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
Metastatic CancerGastrointestinal NeoplasmsGastrointestinal Diseases+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC278 enrolled31 locationsNCT05489237
Recruiting
Not Applicable
BOLSTER: Learning New Skills to Thrive
Advanced CancerGynecologic CancerGastrointestinal Cancer
Dana-Farber Cancer Institute600 enrolled2 locationsNCT06936878
Recruiting
Phase 3
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting
Phase 3
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
GlaxoSmithKline450 enrolled84 locationsNCT07218926
Recruiting
Phase 1Phase 2
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Colorectal, CancerPancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc.1,130 enrolled32 locationsNCT06445062
Recruiting
Phase 1
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Amgen350 enrolled77 locationsNCT06360354
Recruiting
Not Applicable
Traction vs. No Traction in Colonic ESD
Gastrointestinal Neoplasm
Baylor College of Medicine150 enrolled2 locationsNCT06159634
Recruiting
Not Applicable
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Gastrointestinal Neoplasm
Baylor College of Medicine66 enrolled2 locationsNCT06134687
Recruiting
Not Applicable
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
Postoperative ComplicationsAnastomotic LeaksAnastomotic Complication+8 more
Medtronic - MITG137 enrolled8 locationsNCT07351071
Recruiting
Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Gastrointestinal Stromal Tumor (GIST)Gastrointestinal Stromal NeoplasmGastrointestinal Stromal Cancer+2 more
Kura Oncology, Inc.157 enrolled32 locationsNCT06655246
Recruiting
Not Applicable
Telephone Support in Advanced Gastrointestinal Cancer
Caregiver BurdenGastrointestinal Neoplasm Malignant
Indiana University488 enrolled4 locationsNCT06532877
Recruiting
Not Applicable
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
Lung CancerGastrointestinal Cancer
M.D. Anderson Cancer Center200 enrolled1 locationNCT06420206
Recruiting
Phase 1Phase 2
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
Gastrointestinal Neoplasms
GlaxoSmithKline320 enrolled47 locationsNCT06885034
Recruiting
Phase 1
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Uveal MelanomaNeuroendocrine TumorsGastrointestinal Stromal Tumors+4 more
Novelty Nobility, Inc.67 enrolled5 locationsNCT06805825
Recruiting
Not Applicable
Improving Comprehensive Care of Cancer Patients
Breast CancerGastrointestinal CancerHematologic Cancer
Baylor College of Medicine340 enrolled1 locationNCT05323409
Recruiting
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
eosinophilic esophagitisEosinophilic GastritisEosinophilic Gastrointestinal Disorders (EGIDs)+2 more
Children's Hospital Medical Center, Cincinnati1,350 enrolled19 locationsNCT02523118
Recruiting
Not Applicable
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
ConstipationAutonomic DysfunctionSystemic Sclerosis+1 more
The University of Texas Health Science Center, Houston60 enrolled1 locationNCT05989763
Recruiting
A Registry for People With T-cell Lymphoma
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+27 more
Memorial Sloan Kettering Cancer Center1,000 enrolled26 locationsNCT05978141
Recruiting
Phase 1Phase 2
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
NeoplasmsNeoplasm MetastasisMetastatic Gastrointestinal Carcinoid Tumor
Shanghai EpimAb Biotherapeutics Co., Ltd.152 enrolled14 locationsNCT05176665